PATENT CLAIM ANALYSIS

Application Number: 16400514
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-08
Patent Classification: ["514", "635000"]

Abstract:
The present invention relates to a pharmaceutical composition for inhibiting growth of cancer stem cells, containing an aldehyde inhibitor and a biguanide-based compound. The pharmaceutical composition according to the present invention contains a combination of an aldehyde inhibitor and a biguanide-based compound, which can effectively inhibit the growth of cancer stem cells such as neurospheres and can also inhibit the proliferation, invasion and metastasis of cancer cells, thereby preventing and/or treating cancer such as brain cancer.

Claim (Index 16):
The method of  claim 11 , wherein the inhibiting of the growth of the brain cancer stem cells is inhibition of brain cancer stem cell maintenance, inhibition of brain cancer stem cell malignancy, or inhibition of brain cancer stem cell invasion.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 100.0
- Lexical Diversity: 1.86364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13089217', '15533842', '15121838', '15040002', '12994960']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7604745129131653
- 35 USC 102 Novelty (BERT): 0.4989168462690546
- Combined Prediction Score: 0.7343187462487542
- Mean Citation Score: 202.067932
- Max Citation Score: 210.94104
- Similarity Product: 140.07676449535842

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test